MGTX
MeiraGTx Holdings plc
NASDAQ · Healthcare · Biotechnology · US
$13.25
+1.53%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.46
- Revenue estimate
- $7.1M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- $1.71
- EPS estimate
- -$0.46
- Revenue actual
- —
- Revenue estimate
- $700.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +137.1%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $24
- PT range
- $20 – $27
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.46 | $1.71 | Beat 473.09% | — |
| Apr 16, 2026 | -$0.43 | -$0.57 | Miss -32.56% | — |
| Mar 26, 2026 | -$0.60 | $0.19 | Beat 131.67% | — |
| Nov 13, 2025 | -$0.50 | -$0.62 | Miss -24.00% | $410.0K |
| Aug 14, 2025 | -$0.52 | -$0.48 | Beat 7.69% | $3.7M |
| Mar 13, 2025 | -$0.48 | -$0.50 | Miss -4.17% | $21.4M |
| May 9, 2024 | -$0.32 | -$0.77 | Miss -140.63% | $697.0K |
| Mar 14, 2024 | -$0.46 | -$0.47 | Miss -2.17% | $2.0M |
| Nov 14, 2023 | -$0.63 | -$0.74 | Miss -17.46% | $5.1M |
| Aug 10, 2023 | -$0.59 | -$0.53 | Beat 10.17% | $3.5M |
| May 11, 2023 | -$0.65 | -$0.62 | Beat 4.62% | $3.3M |
| Mar 14, 2023 | $0.49 | -$0.58 | Miss -218.37% | $5.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026